Company

Versartis, Inc.

Versartis develops treatments for growth hormone deficiency and related disorders.

About

Founded in 2008 and based in Redwood City, US, Versartis is a biopharmaceutical company focused on growth hormone deficiency treatments for adults and children. It went public in March 2014, raising USD 126 mn through its IPO. Its CEOs are Gail McIntyre and Jeffrey Cleland.

6Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in